Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2′-deoxyuridine-Reference-Cited by-同舟云学术

Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2′-deoxyuridine

Published:1991-07 Issue:4 Volume:28 Page:241-250
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Muggia Franco M.,Chan Kenneth K.,Russell Christy,Colombo Nicoletta,Speyer James L.,Sehgal Kishore,Jeffers Susan,Sorich Joan,Leichman Lawrence,Beller Uziel,Beckman E. Mark

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/BF00685529.pdf

Reference33 articles.

1. Arbuck SG, Trave F, Douglass HO Jr, Nava H, Zakrzewski S, Rustum YM (1986) Phase I and pharmacologic studies of intraperitoneal leucovorin and 5-fluorouracil in patients with advanced cancer. J Clin Oncol 4: 1510–1517

2. Au JL, Rustum YM, Ledesma EJ, Mittelman A, Creaven PJ (1982) 5-Fluorouracil and thymidine in treatment of colorectal carcinoma. Cancer Res 42: 2930–2937

3. Aubert C, Somadossi JP, Gassolo P, Cano JP, Rigault JP (1982) Quantitative analysis of 5-fluorouracil and 5,6-dihydrofluorouracil in plasma by gas chromatography mass spectrometry. Biomed Mass Spectrom 9: 336–339

4. Bolger MB, Muir KT (1986) PLOT4U: an interactive graphics and nonlinear regression program for the analysis of experimental and simulated data. Proceedings, Summer Computer Simulation Conference, Society for Computer Simulation, July 28–30, Reno, Nevada

5. Braly P, Hoff S, Leong L, Margolin K, Carr B, Akman S, Doroshow J (1987) Intraperitoneal cisplatin and 5-fluorouracil. Proceedings, 2nd International Conference on Intracavitary Therapy. San Diego, February